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Abstract
Background: There is an increasing number of novel antilipidemic therapies under consideration. The putative
hypolipidemic effect of N-acetylcysteine (NAC) and sesame oil was studied in a mouse model of dietary-induced
hypercholesterolemia.
Methods: Male C57bl/6 mice were assigned to the following groups: (NC) control group, (HC) group receiving test
diet supplemented with 2% cholesterol and 0.5% cholic acid for 8 weeks, (HCN) group receiving the test diet with
NAC supplementation (230 mg/kg p.o.) and (HCS) group fed the test diet enriched with 10% sesame oil. Total
serum cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides were assayed at the beginning and at the end
of the experiment. Total peroxides and nitric oxide (NO) levels were measured in the serum at the end of the
experiment. Hepatic and aortic lesions were evaluated by haematoxylin-eosin staining.
Results: Higher serum levels of total and LDL-cholesterol were recorded in all groups fed the high cholesterol diet.
The HCN group presented reduced lipid levels compared to HC and HCS groups. No differences were observed
between HCS and HC groups. Peroxide content in serum was markedly increased in mice consuming high
cholesterol diet. NAC and sesame oil administration led to a significant decrease of serum lipid peroxidation in the
levels of control group, whereas only NAC restored NO bioavailability. In terms of liver histology, the lesions
observed in HCN group were less severe than those seen in the other high cholesterol groups.
Conclusion: Co-administration of NAC, but not sesame oil, restored the disturbed lipid profile and improved
hepatic steatosis in the studied diet-induced hypercholesterolemic mice. Both agents appear to ameliorate serum
antioxidant defense.
Background
Hypercholesterolemia in combination with raised LDL-
cholesterol concentration represent major risk factors
for the development and progression of atherosclerosis
and consequently of cardiovascular disease [1]. Based on
this evidence, scientific research is targeting the discov-
ery of new drugs with hypocholesterolemic effects. Plant
based dietary therapies and natural food components
are being proposed nowadays for the prevention of dys-
lipidemia. The antioxidant N-acetylcysteine (NAC), an
organosulfur from Allium plants and sesame oil appear
as promising lipid-lowering agents in recent literature.
NAC is a hydrophilic cysteine-containing compound
naturally formed in Allium plants such as garlic and
onion. The intake of this compound was found to effec-
tively decrease high saturated fat-induced triacylglycerol
(TAG) and cholesterol accumulation in mice livers.
Moreover it has been shown to protect the liver against
high fat-induced oxidative damage [2].
Sesame belongs to the species Sesamum indicum (Ped-
aliaceae family). It has been extensively used as a tradi-
tional food in the orient but it is also considered to
have important medical properties. There is abundant
data available from different studies mainly on rodent
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components of sesame seed and its oil [3,4]. Satchitha-
nandam et al [4] concluded that the absorption of lym-
phatic cholesterol in rats fed diets containing sesame oil
was about 50% less than by rats fed a control diet. Addi-
tionally, administration of non defatted sesame seed
powder in hypercholesterolemic albino rats, improved
their antioxidant status and significantly decreased
plasma lipids [5]. To our knowledge there is no litera-
ture-based evidence of the potential hypolipidemic
effects of sesame oil administration without substitution
of other fat dietary compounds.
Therefore, the present study was undertaken to deter-
mine whether NAC and sesame oil administration
would have beneficial hypolipidemic and antioxidant
effects in a murine model consuming a chow diet,
enriched with cholesterol and cholic acid.
Methods
Animals
12-week-old C57bl/6 male mice (Mus musculus)w e r e
obtained from Alexander Fleming Institute (Vari, Greece)
and were acclimatised for one week before the experi-
ment started. The animals were housed under conditions
of controlled temperature (23 ± 2°C) and humidity (60%)
with 12 h light/dark cycle. The experimental protocol
was reviewed and approved by the Veterinary Directorate
of Athens Prefecture and by the Ethics Committee of the
Medicine School of the National and Kapodistrian Uni-
versity of Athens, in accordance with ethical recommen-
dation of the European Communities Council Directive
of November 24, 1986 (86/609/EEC).
Experimental design
A total of 25 mice were divided into the following 4
experimental groups:
NC (n = 5): normal control with basal diet (4RF25,
Mucedola, Milan, Italy); HC (n = 5): animals that
received the normal chow diet supplemented with cho-
lesterol (2%) and cholic acid (0.5%) (high cholesterol
diet) for 8 weeks; HCN (n = 7): animals fed the high
cholesterol diet with NAC (Flumil Antidoto, IFET,
Greece). NAC was administrated p.o. in drinking water
in a concentration tested to result in a daily uptake of
approximately 230 mg/kg body weight. The dosage of
the drug was determined according to previous reports
on rodents [6,7]. HCS (n = 8): mice which received the
high cholesterol diet enriched with 10% sesame oil for
the same period. Sesame oil was obtained from a local
health food store. High cholesterol content was used in
the high cholesterol diet in order to obtain hypercholes-
terolemia after a short follow-up period. Cholesterol and
cholic acid (approximately 95% and 99% purity
respectively) were obtained from Sigma-Aldrich (Ger-
many). The high cholesterol diet was prepared weekly
by dissolving cholesterol in diethyl ether (without buty-
lated hydroxytoluene as inhibitor) and cholic acid in
methanol and thoroughly coating with these solutions
the pellets of standard chow cut in small pieces. After
solvent evaporation, the chow was stored at -20°C until
use. Fresh food from the freezer was provided to the
animals every day while food remaining from the pre-
vious day was removed. The appropriate quantity (corre-
sponding to daily uptake) of this high cholesterol diet
was first weighed, mixed thoroughly with the appropri-
ate amount of sesame oil and then dried and weighed
again in order to achieve a final concentration of sesame
oil in mice diet at a level of 10%.
Mice had free access to eat and drink throughout the
study. During the 8-week period, food consumption was
monitored daily, whereas the amount of water con-
sumed daily was also recorded in HCN group. Mice
were weighed once a week.
Blood collection and serum lipid measurement
Blood samples of mice were collected at the beginning
and at the end of the experimental period (at 9:00 am,
after a 12-h fasting period), using capillary tubes intro-
duced into the medial retro-orbital venous plexus under
light ether anaesthesia. A quantity of about 150-200 μl
of blood was collected from each mice at the beginning
of the experiment. Bigger quantity of blood (400 - 500
μl) was collected at the end of the experiment and
before mice’s euthanasia. Serum was separated by cen-
trifugation at 3000 rpm for 10 min and was stored at
-80°C until analysis.
Serum concentrations of total cholesterol and of trigly-
cerides were determined using the enzymatic PAP com-
mercial kit ("biosis” - Biotechnological Applications,
Athens, GR) and HDL-cholesterol was determined with a
cholesterol enzymatic photometric method. LDL-choles-
terol was determined by the mathematic model “LDL-cho-
lesterol = Total Cholesterol- (HDL-cholesterol +
Triglycerides/5)”.
All samples were analyzed at the Laboratory of Experi-
mental Surgery and Research of the Medical School of
Athens (Athens, Greece).
Serum lipid peroxidation - NO levels determination
Total peroxide concentration in collected serum was
assessed photometrically (PerOx kit, Immundiagnostic
AG, Bensheim, Germany). Total serum nitric oxide (NO)
was calculated based on the enzymatic conversion of
nitrate to nitrite by nitrate reductase, using a commercial
kit (Total Nitric Oxide and Nitrate/Nitrite Parameter
Assay Kit, R&D SYSTEMS, Minneapolis, MN, U.S.).
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At the end of the 8-week period, animals were eutha-
nized under ether anaesthesia with their livers and aor-
tas dissected immediately for further histopathological
analysis. Part of the livers and aortas were fixed in 10%
formalin at room temperature. The tissues were then
embedded in paraffin, sectioned and mounted on glass
microscope slides. The sections were stained with hema-
toxylin-eosin and examined blindly by two independent
researchers using light microscopy. More precisely, the
liver was evaluated as had been previously described by
the Pathology Committee of non-alcoholic steatohepati-
tis Clinical Research Network [8]. The histological fea-
tures were grouped into 4 broad categories: steatosis,
ballooning, portal inflammation and lobular activity. A
score from 0 (absence) to 3 (severe lesion) was assigned
to each parameter.
Statistical evaluation
All of the analyses were performed using the SPSS sta-
tistical software. The results were expressed as mean
values ± standard errors and analyzed for statistical sig-
nificance by One Way ANOVA test. Liver lesions were
demonstrated as mean score ± standard errors for stea-
tosis, ballooning, portal inflammation and lobular activ-
ity. Statistical significance was set at P < 0.05.
Results
Body weight and food and water intake
In the present study the initial body weight for all groups
w a ss i m i l a r .A tt h ee n do ft h e8 - w e e ks t u d yt h em i c eo f
the HC group presented reduced body weight compared
to the animals in the NC (P = 0.027), HCN (P = 0.018)
and HCS (P = 0.002) groups (Table 1). A statistically sig-
nificant increase was observed in food consumption in
the HCN group relative to the NC (P < 0.001) and HCS
(P < 0.001) group. The daily water volume consumed by
the mice in HCN group was 4.36 ± 0.15 mL.
Serum lipid profile
At the initial blood sampling, no differences in lipid
levels (except LDL-cholesterol, Table 1) were recorded
among the groups. Feeding of the high cholesterol diet
containing 2% cholesterol and 0.5% cholic acid for the
period of 8 weeks resulted in the development of hyper-
lipidemia in experimental mice groups compared to the
control group. Serum total cholesterol and LDL-choles-
terol levels (Table 1) were significantly increased in the
three groups fed the high cholesterol diet compared to
the NC group (P < 0.001).
NAC co-administration markedly reduced total cho-
lesterol (P = 0.013) and LDL-cholesterol (P = 0.012)
levels compared to the HC group. Although there was a
slight decrease in total cholesterol and LDL-cholesterol
in HCS compared to the HC group, this reduction was
not statistically significant. HDL-cholesterol levels were
found to be decreased in HCS group compared to NC
group (P = 0.006), whereas there was no difference
between the other groups. Lower concentrations of tri-
glyceride levels were observed in all groups fed the high
cholesterol diet in comparison to the control group
(P < 0.001).
Serum lipid peroxidation - NO levels determination
The evaluation of peroxidation products showed that
peroxide content in the serum was markedly altered in
the HC group related to the other three experimental
groups (Figure 1). Both NAC and sesame oil administra-
tion reduced serum peroxidation to the levels of the
control group, improving antioxidant status (Figure 1).
NO serum levels (Figure 2) were reduced in the HC
group in comparison to the control group, whereas the
difference was marginal between the HC and the HCS
group. Nevertheless, the HCN group presented signifi-
cantly elevated NO levels compared to the HC group
preserving it at its normal level for mice.
Liver and aorta histopathology
Hematoxylin-eosin stained liver samples, obtained from
the groups fed the high cholesterol diet, showed signs of
liver steatosis and inflammation (Figure 3). A significant
increase in accumulation of fat droplets was observed in
the livers of the HC and HCS groups compared to the
NC group [HC and HCS groups vs NC, (P = 0.001) and
(P < 0.001) respectively] (Table 2). This increase was
apparently suppressed in HCN group of mice in com-
parison to the HC group (P = 0.001), whereas no differ-
ence was observed between HCN and NC groups
(P = 0.763). Moreover, the architecture of hepatocytes
i nt h eH C Ng r o u pw a sf o u n dt ob em o r es i m i l a rt oN C
g r o u pc o m p a r e dt ot h a to ft h eH Ca n dH C Sg r o u p s
(Figure 3). Ballooning of hepatocytes and lobular activity
were observed in liver tissues of all mice in the HC and
HCS groups, as compared to only two of the seven ani-
mals of HCN group. Neither NAC nor sesame oil
administration improved hepatic inflammation. The
grade of fatty liver disease was considered as “mild” in
t h r e eo ft h es e v e nm i c ei nH C Ng r o u p .I nf i v em i c e
from the HC group, the grade was “severe” in three,
“moderate” in one and “mild” also in one mouse.
In evaluating the total examined parameters in hepatic
tissue of mice, we conclude that NAC administration
improved liver histology whereas diet supplementation
with sesame oil had negative effects.
No fatty streaks or plaques were recorded in aortic tis-
sues of all experimental mice (data non shown).
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Hypercholesterolemia is one major risk factor for the
development of atherosclerosis. The present study
focused on the possible antilipidemic effect of NAC and
sesame oil administration in hypercholesterolemic mice.
To the best of our knowledge, this is the first study that
investigated NAC and sesame oil action on the lipid
profiles of mice consuming a chow diet enriched with
cholesterol and cholic acid.
Cholesterol-cholic acid feeding has often been used
to raise cholesterol levels in plasma and tissues of
experimental animals [9,10]. The experimental diet fol-
lowed in the present study resulted in elevated total
cholesterol and LDL-cholesterol levels in all mice receiv-
ing it. Triglyceride levels decreased in all groups fed the
high cholesterol-cholic acid diet. This finding is in
accordance with previous studies in mice and rat groups
fed with diets containing cholic acid or cholate [11,12].
Furthermore, according to the study of Kamisako et al.
[13] there was a slight decrease in triglyceride levels of
rats fed a diet containing 1% cholic acid as compared to
their control counterparts. Li et al. [11] assumed that
the triglycerides reduction in their study might be a
consequence of the inhibition on 7a-hydroxylase activity
due to the presence of the cholate in the experimental
atherogenic diet, something that is not in accordance
Table 1 Body weight and food consumption
Groups
Measurements NC HC HCN HCS
Initial Body Weight (g) 23 ± 0.45 22.40 ± 0.40 22.85 ± 0.40 23.50 ± 0.33
Final Body Weight (g) 24.3 ± 0.61
b 22 ± 0.63
acd 24.28 ± 0.52
b 25.25 ± 0.53
b
Food Consumption (g/day) 3.25 ± 0.03
a 3.38 ± 0. 04 3.52 ± 0. 05
ad 3.23 ± 0. 05
a
Total cholesterol (mg/dL) Time 0 94.00 ± 6.31 85.50 ± 7.34 83.25 ± 4.33 88.62 ± 5.22
Time 1 95.60 ± 4.15
bcd 203.4 ± 11.29
ac 158.57 ± 5.38
ab 188.12 ± 15.09
a
LDL-cholesterol (mg/dL) Time 0 22.13 ± 3.83
bc 8.00 ± 3.61
a 9.85 ± 2.09
a 16.87 ± 1.65
Time 1 23.72 ± 3.93
bcd 147.20 ± 9.95
ac 107.62 ± 4.54
abd 140.72 ± 13.07
ac
HDL-cholesterol (mg/dL) Time 0 48.83 ± 3.80 53.00 ± 5.56 50.25 ± 1.95 50.50 ± 2.22
Time 1 56.20 ± 1.59
d 49.20 ± 4.60 44.28 ± 1.65 41.75 ± 3.85
a
Triglycerides (mg/dL) Time 0 115.16 ± 9.86 139.50 ± 15.84 121.50 ± 8.57 137.25 ± 7.86
Time 1 78.40 ± 8.58
bcd 35.00 ± 1.81
a 33.28 ± 1.70
a 28.25 ± 1.58
a
Body weight at the beginning and at the end of the experimental study, food consumption levels and total cholesterol, LDL-cholesterol, HDL-cholesterol and
triglycerides levels in serum before (Time 0) and after the 8-week experimental period (Time 1)
(NC), Control mice; (HC) mice fed the high cholesterol diet; (HCN) mice fed the high cholesterol diet and treated with NAC; (HCS) fed the high cholesterol diet
enriched with sesame oil.
a: Significantly different from NC group
b: Significantly different from HC group
c: Significantly different from HCN group
d: Significantly different from HCS group
Values are presented as means ± standard error, P <0 . 0 5 .
Figure 1 Total serum Peroxides (μmol/L) at the end of the
8-week experimental period. (NC), Control mice; (HC) mice fed
the high cholesterol diet; (HCN) mice fed the high cholesterol diet
and treated with NAC; (HCS) fed the high cholesterol diet enriched
with sesame oil, P < 0.05.
Figure 2 Total serum NO (μmol/L) at the end of the 8-week
experimental period. (NC), Control mice; (HC) mice fed the high
cholesterol diet; (HCN) mice fed the high cholesterol diet and
treated with NAC; (HCS) fed the high cholesterol diet enriched with
sesame oil, P < 0.05.
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of 7a-hydroxylase activity leads to the increase of trigly-
ceride levels.
Hypercholesterolemia enhances the free radical gen-
eration in various ways [1] and is generally associated
with an increased production of oxygen radicals such us
superoxide anion radical [15]. NAC in our study had
beneficial effects concerning lipid profile. The adminis-
tration of this antioxidant largely prevented the diet
induced increase in serum lipids (total cholesterol and
LDL-cholesterol levels).
NAC has been shown to reduce cholesterol levels in
plasma and liver in Balb/cA mice consuming a high satu-
rated fat diet [2]. Krieger et al. [16] mentioned a slight
reduction in plasma lipid fractions by means of NAC
supplementation in hypercholesterolemic LDL receptor
knockout mice. Therefore, other researchers indicate a
beneficial effect of NAC on dyslipidemic profile of rats
fed a high sucrose diet or of rats given standard chow
and 30% sucrose in their drinking water [17,18]. Putative
mechanisms accounting for the lipid-lowering effects of
NAC might be related to its antioxidant properties. NAC
in our study led to reduced serum peroxide content. The
maintenance of the normal structure of lipoprotein
receptors is indispensable for their function, improving
the cellular uptake of serum lipids from the blood. Reac-
tive oxygen species produced during oxidative stress
react with lipoproteins to produce oxidation states,
diminishing the cellular uptake of lipids from the blood
[17,19,20]. Thus the antioxidant action of NAC might
contribute to elevated cellular lipid uptake, resulting in
the decrease of serum cholesterol levels.
According to Lin and Yin [21], the lipid lowering action
of NAC in mice consuming a high fat diet is attributed
partially to the suppression of mRNA expression of three
lipogenic-related enzymes (malic enzyme, fatty acid
synthase and 3-hydroxy-3-methylglutaryl coenzyme A
reductase).
NO is considered as an important vasoactive sub-
stance which protects the integrity of the blood vessels.
Figure 3 Haematoxylin and eosin staining of hepatic tissue (400×). Control mice (A); mice fed high cholesterol diet (B); mice fed the high
cholesterol diet and treated with NAC (C). Arrow in B. indicates hepatocyte lipid inclusion (steatosis). Note the dark periportal inflammatory
infiltrates in B. and C.
Table 2 Histological observations of hepatic tissue
Groups Steatosis Ballooning Portal inflammation Lobular activity Overall
NC 0.00 ± 0.00
b,d 0.00 ± 0.00
b,d 0.00 ± 0.00
b,c,d 0.00 ± 0.00
b,d 0.00 ± 0.00
b,c,d
HC 2.00 ± 0.31
a,c,d 1.40 ± 0.40
a,c,d 1.80 ± 0.58
a 1.20 ± 0.20
a,c 6.40 ± 0.87
a,c,d
HCN 0.28 ± 0.18
b,d 0.28 ± 0.18
b,d 1.28 ± 0.47
a 0.28 ± 0.18
b,d 2.14 ± 0.59
a,b,d
HCS 3.00 ± 0.00
a,b,c 2.12 ± 0.29
a,c 2.00 ± 0.00
a 1.87 ± 0.29
a,c 9.00 ± 0.18
a,b,c
3, severe; 2, moderate; 1, mild; 0, no changes in histology (scores)
(NC), Control mice; (HC) mice fed high cholesterol diet; (HCN) mice fed the high cholesterol diet and treated with NAC; (HCS) fed the high cholesterol diet
enriched with sesame oil.
a: Significantly different from NC group
b: Significantly different from HC group
c: Significantly different from HCN group
d: Significantly different from HCS group
Values are presented as mean score ± standard error, P < 0.05.
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in rabbits fed a high fat diet. Similar to this study, we
observed that our experimental high cholesterol-cholic
acid diet suppressed serum NO levels, whereas NAC
administration raised NO bioavailability and maintained
it at the normal level. Thus NAC might display an
essential protecting role for the normal function of
arteries.
Our results concerning hepatic steatosis and inflam-
mation are consistent with those of previous investiga-
tions [23]. As previously described, NAC administration
suppresses hepatic lipid infiltration in hepatic tissues of
mice fed high fat diets [21]. The hepatoprotective action
of NAC might be associated with its antioxidant action,
as mentioned above.
Similar to the findings of Sener et al. [9], the choles-
terol-cholic acid diet used in our study did not lead to
fatty streak or plaque formation in aortic tissues of
mice. This finding was partially anticipated, as our test
diet consisted of the regular chow diet (3.5% fat)
enriched with cholesterol and cholic acid without addi-
tional fat. In contrast, diets used for the initiation of
atherosclerosis in wild-type mice like Paigen diet [24,25]
have a final fat composition of more than 15% (in
weight percentage).
Sesame oil supplementation, at a level of 10% in the
t e s td i e t ,f a i l e dt or e s t o r ethe disturbed lipid profile
caused by the high cholesterol-cholic acid diet, despite
the decrease in serum peroxidation. Total cholesterol
and LDL-cholesterol levels exhibited a decrease by
sesame oil administration. This preventive effect how-
ever could not be statistically confirmed, probably due
to the limited number of available observations or/and
to the elevated caloric value of the sesame oil modified
diet. In addition, we observed that sesame oil co-admin-
istration enhanced hepatic steatosis and inflammation.
Administration of dietary defatted sesame flour to rab-
bits did not protect against cholesterol-induced hyperch-
olesterolemia, but decreased the susceptibility to
oxidative stress (lower serum and liver lipid peroxida-
tion) perhaps due to the antioxidant activity of sesami-
nol [26]. Bhaskaran et al. [27] reported a significant
reduction in plasma cholesterol, LDL-cholesterol and
triglycerides levels in LDLR-/- mice when their athero-
genic diet was reformulated with the same level of
sesame oil. In our study, sesame oil was added to the
test diet without fat substitution. The additional calories
of the sesame oil diet might resulted in the absence of
hypolipidemic response, as mentioned above.
In an earlier study, an increase was shown in the hyper-
lipidemic status of rabbits fed a hypercholesterolemic diet
enriched with olive oil [28], whereas Acin et al. [29] con-
cluded that dietary cholesterol suppresses the ability of
olive oil to delay the development of atherosclerotic
lesions in mice, negatively influencing their plasma lipid
parameters. Therefore we can assume that cholesterol
addition, like in the case of olive oil, in part suppresses
the putative hypolipidemic action of sesame oil.
In summary, even though sesame oil presented antiox-
idant properties, it did not show significant hypolipi-
d e m i ca c t i v i t yi nm i c ec o n s u m i n gac h o wd i e te n r i c h e d
with cholesterol and cholic acid. NAC administration
was able to improve lipidemic status in the serum, to
maintain liver physiology and to reduce serum peroxides
probably by ameliorating the efficiency of the antioxi-
dant defence system of experimental animals. Moreover,
NAC might exert preventive antiatherogenic activity by
means of raised serum NO levels.
Conclusions
Co-administration of NAC, but not sesame oil, restored
the disturbed lipid profile and hepatic injury in the stu-
died hypercholesterolemic murine model, although both
agents enhanced serum antioxidant capacity. Thus NAC
might represent a beneficial alternative for lowering
cholesterol levels in humans during clinical practice.
Abbreviations
(NAC): N-acetylcysteine; (NC): control group; (HC): group receiving test diet
supplemented with cholesterol and cholic acid; (HCN): group receiving the
test diet with NAC supplementation; (HCS): group fed the test diet enriched
with sesame oil; (LDL): low density lipoprotein; (HDL): high density
lipoprotein; (NO): nitric oxide.
Acknowledgements
We wish to thank Mrs Kalliopi N. Perrea for her kind assistance in laboratory
techniques.
Author details
1Department of Experimental Surgery and Surgical Research ‘NS Christeas’,
Athens School of Medicine, Athens, Greece.
2Department of Pathology,
Athens School of Medicine, Athens, Greece.
Authors’ contributions
LMK has been involved in experimental design, animal experiments,
laboratory analysis, data collection and statistical analysis. GA carried out the
histopathological examination. AP has been involved in experimental design
and animal experiments. ISV participated in experimental design and
performed part of the statistics. DI and TK have been involved in
experimental design. DNP participated in experimental design, animal
experiments, laboratory analysis and data collection. All of the above helped
in drafting the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 26 January 2010 Accepted: 6 March 2010
Published: 6 March 2010
References
1. Prasad K, Kalra J: Oxygen free radicals and hypercholesterolaemic
atherosclerosis: effect of Vitamin E. American Heart Journal 1993,
125:958-973.
2. Lin CC, Yin MC, Hsu CC, Lin MP: Effect of five cysteine-containing
compounds on three lipogenic enzymes in Balb/cA mice consuming a
high saturated fat diet. Lipids 2004, 39:843-848.
Korou et al. Lipids in Health and Disease 2010, 9:23
http://www.lipidworld.com/content/9/1/23
Page 6 of 73. Rajamohan T, Kurup PA: Lysine: arginine ratio of a protein influences
cholesterol metabolism. Part 1-Studies on sesame protein having low
lysine: arginine ratio. Indian J Exp Biol 1997, 35:1218-1223.
4. Satchithanandam S, Chanderbhan R, Kharroubi AT, Calvert RJ, Klurfeld D,
Tepper SA, Kritchevsky D: Effect of sesame oil on serum and liver lipid
profiles in the rat. Int J Vitam Nutr Res 1996, 66:386-392.
5. Visavadiya NP, Narasimhacharya AV: Sesame as a hypocholesteraemic and
antioxidant dietary component. Food Chem Toxicol 2008, 46:1889-1895.
6. Ivanovski O, Szumilak D, Nguyen-Khoa T, Ruellan N, Phan O, Lacour B,
Descamps-Latscha B, Drüeke TB, Massy ZA: The antioxidant N-
acetylcysteine prevents accelerated atherosclerosis in uremic
apolipoprotein E knockout mice. Kidney Int 2005, 67:2288-2294.
7. Koros C, Papalexi E, Anastasopoulos D, Kittas C, Kitraki E: Effects of AraC
treatment on motor coordination and cerebellar cytoarchitecture in the
adult rat. A possible protective role of NAC. Neurotoxicology 2007,
28:83-92.
8. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW,
Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ,
Sanyal AJ: Nonalcoholic Steatohepatitis Clinical Research Network.
Design and validation of a histological scoring system for nonalcoholic
fatty liver disease. Hepatology 2005, 41:1313-1321.
9. Sener G, Balkan J, Cevikbaş U, Keyer-Uysal M, Uysal M: Melatonin reduces
cholesterol accumulation and prooxidant state induced by high
cholesterol diet in the plasma, the liver and probably in the aorta of
C57BL/6J mice. J Pineal Res 2004, 36:212-216.
10. Chen W, Matuda K, Nishimura N, Yokogoshi H: The effect of taurine on
cholesterol degradation in mice fed a high-cholesterol diet. Life Sci 2004,
74:1889-1898.
11. Li Y, Gilbert TR, Matsumoto AH, Shi W: Effect of aging on fatty streak
formation in a diet-induced mouse model of atherosclerosis. J Vasc Res
2008, 45:205-210.
12. George J, Mulkins M, Casey S, Schatzman R, Sigal E, Harats D: The effects of
N-6 polyunsaturated fatty acid supplementation on the lipid
composition and atherogenesis in mouse models of atherosclerosis.
Atherosclerosis 2000, 150:285-293.
13. Kamisako T, Ogawa H, Yamamoto K: Effect of cholesterol, cholic acid and
cholestyramine administration on the intestinal mRNA expressions
related to cholesterol and bile acid metabolism in the rat. J Gastroenterol
Hepatol 2007, 22:1832-1837.
14. Beigneux A, Hofmann AF, Young SG: Human CYP7A1 deficiency: progress
and enigmas. J Clin Invest 2002, 110:29-31.
15. Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F,
Cipollone F, Bon GB, Ciabattoni G, Patrono C: In vivo formation of 8-Epi-
prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler
Thromb Vasc Biol 1997, 17:3230-3235.
16. Krieger MH, Santos KF, Shishido SM, Wanschel AC, Estrela HF, Santos L, De
Oliveira MG, Franchini KG, Spadari-Bratfisch RC, Laurindo FR:
Antiatherogenic effects of S-nitroso-N-acetylcysteine in
hypercholesterolemic LDL receptor knockout mice. Nitric Oxide 2006,
14:12-20.
17. Diniz YS, Rocha KK, Souza GA, Galhardi CM, Ebaid GM, Rodrigues HG,
Novelli Filho JL, Cicogna AC, Novelli EL: Effects of N-acetylcysteine on
sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative
stress in rats. Eur J Pharmacol 2006, 543:151-157.
18. Souza GA, Ebaid GX, Seiva FR, Rocha KH, Galhardi CM, Mani F, Novelli EL: N-
Acetylcysteine an Allium plant compound improves high-sucrose diet-
induced obesity and related effects. Evid Based Complement Alternat Med
2008, doi: 10.1093/ecam/nen070.
19. Schaffer JE: Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003,
14:281-287.
20. Brizzi P, Tonolo G, Carusillo F, Malaguarnera M, Maioli M, Musumeci S:
Plasma lipid composition and LDL oxidation. Clin Chem Lab Med 2003,
41:56-60.
21. Lin CC, Yin MC: Effects of cysteine-containing compounds on
biosynthesis of triacylglycerol and cholesterol and anti-oxidative
protection in liver from mice consuming a high-fat diet. Br J Nutr 2008,
99:37-43.
22. Hu MY, Li YL, Jiang CH, Liu ZQ, Qu SL, Huang YM: Comparison of
lycopene and fluvastatin effects on atherosclerosis induced by a high-fat
diet in rabbits. Nutrition 2008, 24:1030-1038.
23. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D,
Kerksiek A, van Kruchten R, Maeda N, Staels B, van Bilsen M, Shiri-
Sverdlov R, Hofker MH: Dietary cholesterol, rather than liver steatosis,
leads to hepatic inflammation in hyperlipidemic mouse models of
nonalcoholic steatohepatitis. Hepatology 2008, 48:474-486.
24. Paigen B: Genetics of responsiveness to high-fat and high-cholesterol
diets in the mouse. Am J Clin Nutr 1995, 62:458S-462S.
25. Getz GS, Reardon CA: Diet and murine atherosclerosis. Arterioscler Thromb
Vasc Biol 2006, 26:242-249.
26. Kang MH, Kawai Y, Naito M, Osawa T: Dietary defatted sesame flour
decreases susceptibility to oxidative stress in hypercholesterolemic
rabbits. J Nutr 1999, 129:1885-1890.
27. Bhaskaran S, Santanam N, Penumetcha M, Parthasarathy S: Inhibition of
atherosclerosis in low-density lipoprotein receptor-negative mice by
sesame oil. J Med Food 2006, 9:487-490.
28. Karantonis HC, Antonopoulou S, Perrea DN, Sokolis DP, Theocharis SE,
Kavantzas N, Iliopoulos DG, Demopoulos CA: In vivo antiatherogenic
properties of olive oil and its constituent lipid classes in hyperlipidemic
rabbits. Nutr Metab Cardiovasc Dis 2006, 16:174-185.
29. Acín S, Navarro MA, Carnicer R, Arbonés-Mainar JM, Guzmán MA, Arnal C,
Beltrán G, Uceda M, Maeda N, Osada J: Dietary cholesterol suppresses the
ability of olive oil to delay the development of atherosclerotic lesions in
apolipoprotein E knockout mice. Atherosclerosis 2005, 18:17-28.
doi:10.1186/1476-511X-9-23
Cite this article as: Korou et al.: Comparative antilipidemic effect of
N-acetylcysteine and sesame oil administration in diet-induced
hypercholesterolemic mice. Lipids in Health and Disease 2010 9:23.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Korou et al. Lipids in Health and Disease 2010, 9:23
http://www.lipidworld.com/content/9/1/23
Page 7 of 7